Glem-LinXR
Empagliflozin + Linagliptin + Metformin Hydrochloride Extended Release
Product overview
Regulatory-friendly overview of dosage forms and commercial presentations.
This page summarizes the current product entry from the supplied catalogue source.
Active ingredient
Empagliflozin + Linagliptin + Metformin Hydrochloride Extended Release
Therapeutic area
Hypoglycemics
Available dosage forms
Tablet
Available strengths
5mg + 2.5mg + 1000mg; 10mg + 5mg + 1000mg; 12.5mg + 2.5mg + 1000mg; 25mg + 5mg + 1000mg;
Pack sizes
14’s
Presentations
1
Regulatory note
This catalogue is informational only. Pricing, promotional claims, and market-specific availability are not shown.
Catalogue access
Need the complete portfolio? Download the source file used for this catalogue.
Commercial presentations
Glem-LinXR
Available strengths and pack sizes are listed below exactly as provided in the source file.
| Therapeutic area | Generic | Dosage form | Strength | Pack size |
|---|---|---|---|---|
| Hypoglycemics | Empagliflozin + Linagliptin + Metformin Hydrochloride Extended Release | Tablet | 5mg + 2.5mg + 1000mg; 10mg + 5mg + 1000mg; 12.5mg + 2.5mg + 1000mg; 25mg + 5mg + 1000mg; | 14’s |